Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

RCKT holding history

Rocket Pharmaceuticals, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RCKT overviewAll 13F holders of RCKTFull Q2 2026 holdings

Shares (Q2 2026)
1,198
Value
$4.10K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RCKT by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,198$4.10K<0.1%−626−34.3%ReducedHolders
Q1 20261,824$6.53K<0.1%−1,163−38.9%ReducedHolders
Q4 20252,987$10.5K<0.1%+2,040+215.4%AddedHolders
Q3 2025947$3.09K<0.1%−649−40.7%ReducedHolders
Q2 20251,596$3.91K<0.1%+182+12.9%AddedHolders
Q1 20251,414$9.43K<0.1%−58−3.9%ReducedHolders
Q4 20241,472$18.5K<0.1%+620+72.8%AddedHolders
Q3 2024852$15.7K<0.1%−230−21.3%ReducedHolders
Q2 20241,082$23.3K<0.1%−1,095−50.3%ReducedHolders
Q1 20242,177$58.6K<0.1%−4,190−65.8%ReducedHolders
Q4 20236,367$190.8K<0.1%−3,194−33.4%ReducedHolders
Q3 20239,561$195.9K<0.1%+8,230+618.3%AddedHolders
Q2 20231,331$26.4K<0.1%+113+9.3%AddedHolders
Q1 20231,218$20.9K<0.1%+30+2.5%AddedHolders
Q4 20221,188$23.2K<0.1%−91−7.1%ReducedHolders
Q3 20221,279$20.0K<0.1%−346−21.3%ReducedHolders
Q2 20221,625$22.0K<0.1%−8,659−84.2%ReducedHolders
Q1 202210,284$164.0K<0.1%+1,150+12.6%AddedHolders
Q4 20219,134$199.0K<0.1%+1,344+17.3%AddedHolders
Q3 20217,790$233.0K<0.1%+1,902+32.3%AddedHolders
Q2 20215,888$261.0K<0.1%+811+16.0%AddedHolders
Q1 20215,077$225.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.